Home
Conditions
Neoplastic Processes

Clinical trial condition

Neoplastic Processes

Explore clinical trials studying Neoplastic Processes. Study availability and eligibility vary by location and protocol.

3,267 public trials 689 recruiting studies

Refine in advanced search Browse all conditions

Neoplastic Processes trial results

Recruiting

A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)

NCT05118789

Conditions: Locally Advanced Solid Tumor, Metastatic Solid Tumor, Neoplasm Metastasis, +4 more
Locations: UCI Medical Center Orange, California, United States

Stanford Medicine Palo Alto, California, United States

UC Davis Comprehensive Cancer Center Sacramento, California, United States

University of Colorado Cancer Center Denver, Colorado, United States

View all 63 locations

View Trial Details

Recruiting

Detection of Genetic Markers of Lung Cancer

NCT00280202

Conditions: Carcinogenesis, Chromosome Aberrations, Lung Cancer, +10 more
Locations: Hillman Cancer Center Pittsburgh, Pennsylvania, United States

View Trial Details

Recruiting

A Study to Evaluate the Impact of Mosunetuzumab Consolidation for Older Patients With Diffuse Large B-cell Lymphoma (DLBCL) Who Have Detectable Amounts of ctDNA (Circulating Tumor DNA) at the End of Treatment With Pola-R-mini-CHP

NCT06828991

Conditions: Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: Wilmot Cancer Institute Rochester, New York, United States

View Trial Details

Recruiting

Spine Radiosurgery for Symptomatic Metastatic Neoplasms

NCT05617716

Conditions: Metastatic Neoplasm, Metastatic Neoplasm to the Spine, Neoplasm Metastasis, +4 more
Locations: Johns Hopkins University Hospitals Baltimore, Maryland, United States

OU Health Stephenson Cancer Center Oklahoma City, Oklahoma, United States

View Trial Details

Recruiting

IFx-Hu2.0 As An Adjunctive Therapy To Pembrolizumab In Advanced Or Metastatic Merkel Cell Carcinoma (MCC)

NCT06940440

Conditions: Adenocarcinoma, Advanced Or Metastatic Merkel Cell Carcinoma, Carcinoma, +18 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

University of Wisconsin Carbone Cancer Center Madison, Wisconsin, United States

View Trial Details

Recruiting

A Study to Provide Continued Access to and Assess Long-Term Safety of the Study Drug(s)

NCT06174987

Conditions: Advanced Cancer, Metastatic Cancer, Neoplasm Metastasis, +4 more
Locations: Miami Cancer Institute Miami, Florida, United States

Duke University - Trent Center Durham, North Carolina, United States

Flinders Medical Center Bedford Park, Australia

Monash Medical Center Melbourne, Australia

View all 28 locations

View Trial Details

Recruiting

ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials

NCT06141993

Conditions: Castration-resistant Prostate Cancer, Genital Diseases, Genital Diseases, Male, +16 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

Duke University Medical Center Durham, North Carolina, United States

University of Wisconsin-Madison Madison, Wisconsin, United States

View Trial Details

Recruiting

Modified Vaccine for High Risk or Low Residual Melanoma Patients

NCT01898039

Conditions: Malignant Melanoma, Melanoma, Neoplasm, Residual, +14 more
Locations: Sharett Institute of Oncology, Hadassah Medical Organization Jerusalem, Israel

View Trial Details

Recruiting

Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers

NCT05296564

Conditions: Adnexal Diseases, Bladder Urothelial Carcinoma, Breast Diseases, +54 more
Locations: Hadassah Medical Organization Jerusalem, Israel

View Trial Details

Recruiting

Comparing Dosing Intervals of Nivolumab or Pembrolizumab in Locally Advanced or Metastatic Cancers

NCT04295863

Conditions: Metastatic Cancer, Neoplasm Metastasis, Neoplasms, +3 more
Locations: University Of Chicago Medicine Comprehensive Cancer Center Chicago, Illinois, United States

SSM Health Cancer Care Madison, Wisconsin, United States

View Trial Details

Neoplastic Processes

Neoplastic Processes trial results

Related conditions